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Abstract
In this review we describe the status of development for a new class of magnetic resonance (MR) 
contrast agents, based on chemical exchange saturation transfer (CEST). The mathematics and 
physics relevant to the description of the CEST effect in MR are presented in an appendix 
published in the online version only. We discuss the issues arising when translating in vitro results 
obtained with CEST agents to using these MR agents in in vivo model studies and in humans. 
Examples are given on how these agents are imaged in vivo. We summarize the status of 
development of these CEST agents, and speculate about the next steps that may be taken towards 
the demonstration of CEST MR imaging in clinical applications.
Keywords
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Contrast in magnetic resonance (MR) images is largely determined by two factors: the 
proton density of the tissue under examination, and the relaxation properties of its protons. 
Conventional contrast agents now widely used in clinical practice work by shortening the 
longitudinal and/or transverse relaxation times of the protons in their close proximity.
While highly useful for the detection of a number of pathologies, such as cancers (1, 2), 
multiple sclerosis (3), and cartilage disease (4), these relaxation agents have a number of 
shortcomings. First, the detection of the agent-induced contrast usually relies on the 
acquisition of precontrast images to help match and identify the enhanced region (once the 
agent is injected, its contrast cannot be turned off). As a consequence, unambiguous contrast 
detection requires relatively large agent doses. Second, although relaxation-based agents 
responsive to the state of their environment (e.g. pH, temperature, etc.) are being developed 
(5), the measured effect is a function of both the environment and the agent concentration, 
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which is usually unknown in vivo. This leads to the difficulty of quantification of the 
environmental parameter of interest. And third, targeted relaxation contrast agents (6) allow 
the imaging of only one target per MRI exam.
All of these shortcomings can in principle be addressed by a new class of MR contrast 
agents called chemical exchange saturation transfer (CEST) agents. These new agents 
introduce image contrast in a fundamentally different way. Their action is not based on 
proton relaxation; instead, they work by selectively reducing the magnetization of the water 
signal, with minimal effects on its longitudinal relaxation rate. This is achieved by using 
molecules that contain exchangeable protons, and a nuclear magnetic resonance (NMR) 
technique introduced by FORSÉN & HOFFMAN in 1963 (7), called magnetization transfer 
NMR (MT-NMR).
MT-NMR was revisited by BALABAN et al. in 2000 (8), who named the contrast 
enhancement procedure chemical exchange saturation transfer (CEST). This name was 
selected to differentiate the approach from a different kind of MT effect in which 
radiofrequency (RF) irradiation of the macromolecules transfers magnetization through 
predominantly cross-relaxation pathways rather than direct chemical exchange (9).
CEST contrast in MR relies on the existence of at least two pools of protons with different 
NMR chemical shifts (Fig. 1). One pool is made up of the exchangeable protons of the 
contrast agent which we refer to as “pool A” throughout this review. The second pool is the 
endogenous bulk water that we refer to as “pool B.” If proton spins in pool A are saturated 
by a continuous frequency-selective RF saturation pulse, exchange of protons from pool A 
to pool B during this saturation period decreases the intensity of pool B spins.
For maximum CEST efficiency, the chemical system must be exchanging slowly on the 
NMR chemical shift time-scale, i.e. τA Δω ⩾ 1 (τA = 1/kA = lifetime of protons in pool A; 
Δω, chemical shift difference between the two pools). A good CEST contrast agent must, 
therefore, possess mobile protons that exchange with water as fast as possible before 
exchange broadening makes selective RF presaturation ineffective. Larger frequency 
separations permit shorter proton lifetimes and thus result in larger CEST effects.
There are two main classes of CEST agents: diamagnetic and paramagnetic agents. 
Although both types of CEST agents rely on exchanging protons, the nature of the 
exchanging protons is different in the two groups. Diamagnetic agents (DIACEST agents, 
which can be small or large molecules) typically rely on exchanging protons belonging to 
−NH and −OH groups whose signals are usually within 5 ppm of the water signal. This 
relatively small chemical shift difference requires slow exchange rates that, in turn, limit the 
observed effect per given injected agent dose. Paramagnetic (PARACEST) agents are 
chelates of paramagnetic (lanthanide) ions that induce much larger shifts in the ligand 
protons up to a few hundred ppm, depending on the lanthanide structure, thus allowing much 
shorter proton lifetimes that still obey the slow exchange condition. PARACEST can be 
single metal-containing chelates, dendrimers, supramolecules, and liposomes, as discussed 
later.
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This review discusses the state of the art of CEST agents. For convenience we have included 
a description of the mathematics and physics of the CEST effect in the Appendix, available 
in the online version of this article: http//www.informahealthcare.com/
10.3109/02841851.2010.502126.
Development of CEST contrast agents for MRI
The first CEST agents were diamagnetic small molecules (DIACEST) containing 
exchangeable −NH or −OH protons, reported by WARD et al. in 2000 (8). Since that time 
there have also been reports of endogenous DIACEST agents. For a typical DIACEST agent, 
whether endogenous or exogenous, the chemical shift difference (Δω) between the 
exchangeable −NH or −OH groups and the bulk water is less than 5 ppm, corresponding to 
~315 Hz at 1.5 T. Using the slow to intermediate exchange conditions of ΔωτA ⩾1 as a 
rough boundary condition for CEST, one would expect CEST to arise only for protons sites 
with an exchange rate in the order of ~2 × 103 s–1 or lower, corresponding to residence 
lifetimes (τA) of ~500μs or longer. This range happens to encompass the exchange lifetimes 
observed for many types of −NH groups and some −OH groups.
However, the relatively small chemical shift difference of DIACEST agents is their major 
disadvantage, since the activation of these exchange groups by semi-selective B1 pulses 
usually also results in partial saturation of bulk water protons (10). This is most problematic 
in vivo where the bulk water proton signal tends to be rather broad. The control experiment 
may also partly saturate the agent-bound protons. Typically two irradiations are needed to 
extract the contrast due to DIACEST agents and calculate the % contrast according to 
Equation 4 in the Appendix. The Appendix is available in the online version of this article: 
http://www.informaworld.com/10.3109/02841851.2010.502126.
The small chemical shift of −NH and −OH protons means that the CEST effects of 
exogenous contrast agents often overlap with strong endogenous MT effects; the separation 
of the two is needed, hence making the detection of the agent more difficult. On the other 
hand, DIACEST agents do not require a paramagnetic metal ion to generate the contrast and, 
therefore, impose no (or reduced) risk of potential toxicity of the contrast agents in the body.
Ideally one would like to increase Δω as much as possible so that the direct saturation of 
water does not arise. This can be achieved by using paramagnetic contrast agents 
(PARACEST agents). The difference between Δω values of a pair of typical DIACEST and 
PARACEST agents is illustrated in Fig. 2.
Fig. 2 clearly shows that CEST activation can be performed much more selectively with the 
PARACEST agent. By expanding the chemical shift difference between the two exchanging 
pools, more rapidly exchanging systems can be used as CEST agents. For example, if Δω is 
increased by a factor of 10 to 50 ppm (equivalent to 3150 Hz at 1.5 T), then the agents with 
exchange lifetimes as short as ~50 s would also meet the slow to intermediate exchange 
condition of ΔωτA ⩾ 1. Consequently, greater image contrast may be obtained for a given 
agent dose, assuming sufficient RF saturation is provided. Additionally, the larger distance 
Hancu et al. Page 3
Acta Radiol. Author manuscript; available in PMC 2019 June 26.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
of the shifted protons from the bulk water signal means significantly reduced MT effects 
from tissue (9).
DIACEST contrast agents
Several classes of diamagnetic CEST compounds have been reported to date including both 
exogenous and endogenous molecules. The exogenous DIACEST agents include small and 
large synthetic molecules, and reporter genes with DIACEST polymer products, as discussed 
briefly below. Endogenous DIACEST agents include proteins, glycogen, and 
glucosaminoglycans. DIACEST agents can be used to image their own presence, the 
presence of other compounds, or environmental factors such as pH, temperature, 
transplanted cells, and progenies of transplanted cells.
Small molecule DIACEST contrast agents
In the first report of diamagnetic CEST agents by WARD et al., candidate molecules were 
chosen based on chemical shift of their exchangeable protons, their rate of chemical 
exchange, and the need to avoid the rapid exchange limit (8). The 35 compounds chosen in 
this first report included sugars, amino acids, neucleocides and their bases, and other 
compounds.
Later, the same group studied a number of pH-responsive CEST agents, including 5,6-
dihydrouracil, 5-hydroxytryptophan, and a combination of 5-hydroxytryptophan and 2-
imidazolidinethione (Fig. 3). They demonstrated that the CEST agent effect on signal 
intensity depends not only on the parameter of interest (here pH), but also on the agent 
concentration, which is always unknown in vivo (11). Among these, 5,6-dihydrouracil is a 
dual CEST agent having two exchangeable protons with exchange rates having different pH 
dependence. The chemical shift separation of these two exchanging sites is sufficient for 
selective independent saturation of the two resonances, thus allowing the measurement of 
two individual CEST effects. Dividing one effect by the other cancels the concentration 
effect, thus allowing pH determination by calibration.
Macromolecular DIACEST contrast agents
Cationic polymers bind DNA and transport it across cell membranes in vivo, and 
GOFFENEY et al. showed that cationic polyamides (Fig. 4) used as gene transport agents 
can also serve as CEST agents (12). The large number of amide protons endows these 
polymers with very high sensitivity. Predictably, agents with slower exchange kinetics (10 
s–1) produced weaker CEST effects, and those with more rapid exchange rates (80–140 s–1) 
had stronger effects. Polymers that exchanged too rapidly to produce a separate observable 
resonance for pool A failed to produce any observable CEST effect.
The benefit of signal amplification by polymeric species also applies to PARACEST agents, 
as mentioned later for Yb3+-DOTAM (13).
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Reporter gene DIACEST contrast agents
Labeling cells for imaging their location, migration pattern, and viability represents an active 
area of MRI research. Most relaxation and CEST contrast agents produce a finite effect that 
undergoes dilution following the division of the labeled cells. This is not necessarily the case 
for genes encoding for CEST agents. For instance, Rat 9L-glioma cells labeled with the gene 
encoding for green fluorescent protein and for a lysine-rich protein (LRP), were transplanted 
into a mouse brain and allowed to grow into a tumor (14). CEST images showed this tumor 
but not similar tumors grown from control cells. The high sensitivity of the LRP reporter 
gene relative to other cell proteins is explained as follows: LRP has many amide protons, all 
resonating within a small spectral range of about 3.76 ppm from water, as compared with the 
broader spectral range of naturally occurring amides. Moreover, the genetically engineered 
gene reporter has faster exchange kinetics than the average amide proton, thus resulting in a 
stronger CEST effect than that of native proteins.
This approach of modifying genes to encode for CEST agents has the added potential of 
imaging cell viability. As healthy cells divide, more LRP is produced, leading to 
correspondingly larger observed CEST effect. Moreover, at physiological pH the amide 
proton exchange is base catalyzed; if the labeled cells migrate to a low pH ischemic 
environment, their detectability by CEST imaging is reduced up to 10-fold for a 1 pH unit. 
Similar effects have also been demonstrated with genes encoding for optical markers; 
however, these markers can only be detected at shallow depths, even with near infrared light. 
Genes encoding for CEST-active proteins are potentially useful for noninvasive whole-body 
imaging.
Paramagnetic lanthanide complexes as PARACEST agents
Paramagnetic lanthanide ions first made an impact in NMR during the early 1970s, with the 
discovery of lanthanide shift reagents (SRs) (15). The first SRs were organic soluble Lewis 
acid-type complexes that spread the proton resonances of organic molecules, essentially 
turning low field nonfirst order NMR spectra into the equivalent of high field first order 
spectra (15, 16). Later it was found that the hyperfine shifts induced by the lanthanide aqua 
ions were also useful in resolving the structures of molecules, such as nucleic acids, 
peptides, proteins, and other biological molecules (17). The hyperfine shifts induced by 
lanthanide ions in proton resonances of a molecule can be quite large, up to several hundred 
ppm, especially for protons that are part of the lanthanide complex itself or when the 
lanthanide is tightly bound at a specific protein binding site.
The next important milestone in NMR application of lanthanides was the introduction of 
Gd3+ complexes as contrast agents for MRI in the early 1980s (18). Gd3+ has seven unpaired 
electrons equally distributed in its 7f orbitals (isotropic), and hence cannot induce hyperfine 
shifts like other lanthanides. Gd3+ does, however, have a profound effect on the relaxation 
rates of nearby nuclei in a complex or any molecule that binds to it or diffuses near the Gd3+ 
complex. This is the foundation for use of Gd3+ as T1 contrast agents for medical MRI (19, 
20).
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Other paramagnetic lanthanides had enjoyed far fewer applications in imaging until the 
discovery of PARACEST (21). As illustrated above, Δω is an important parameter in CEST 
applications, so the same hyperfine shifting characteristics of lanthanide ions have once 
again become the focus of attention. The CJ constants (Table 1) derived by BLEANEY et al. 
(22, 23) provide a useful reference for predicting the relative hyperfine shifting ability of 
various lanthanide cations.
Modulation of water exchange rates in lanthanide complexes
An important physical characteristic of lanthanides as PARACEST contrast agents is the rate 
of water exchange in their complex. Interestingly, however, fast water exchange that is 
desirable to increase the relaxivity of Gd3+-based T1 agents is detrimental in PARACEST-
based systems. In fact water exchange in lanthanide complexes was considered much too 
fast for CEST imaging until the discovery that the exchange rate in Gd3+ complexes of bis-
amide derivatives of diethylenetriamine pentaacetate (DTPA), such as gadolinium(III) 
diethylenetriamine pentaacetate-bismethyl amide (GdDTPA-BMA) is unexpectedly slow, 
with τA values in the range of 1–3μs (24). This realization opened the door to 
comprehensive studies of water exchange rates in lanthanide complexes. For instance, Eu3+ 
complexes of DOTA-tetraamide derivatives, a representative structure of which is shown in 
Fig. 2, have been reported with bound water lifetimes as slow as 200–300μs; clearly, such 
slow water exchange makes these complexes suitable for PARACEST imaging applications 
(21).
Lanthanide complexes that are stable enough for in vivo applications have one water 
molecule coordinated directly to the metal ion (20), which exchanges with the bulk water 
molecules. The rate of water exchange is in direct relationship to the metal ion’s requirement 
for electron density from the water molecule. Thus, the extent to which other ligands provide 
electron density to the metal ion influences the water exchange rate and the CEST effect.
For instance, consider the ligand series shown in Fig. 5, which contains a carboxylate, amide 
or keto group. The carboxylate group, as in DTPA or DOTA ligands, contributes the most 
electron density to the lanthanide ion, which results in complexes that exhibit the fastest 
water exchange in this series. The ligand containing the amide group has a somewhat slower 
water exchange because amide oxygens are much weaker electron donors than carboxylates. 
This increases the demand for electrons from the water molecule on the lanthanide ion. 
Thus, ligands with ligating amide group, as in diethylenetriamine pentaacetate-bismethyl 
amide (DTPA-BMA) or DOTA-tetraamides, have much slower water exchange (24, 25). 
Although water-soluble ketone-type systems have not, to our knowledge, been reported, one 
would predict that such ligands would display the slowest water exchange of the series due 
to their very poor electron donor character.
Design and development of responsive PARACEST agents
If the water exchange rate (kA) or the chemical shift difference (Δω) of a CEST agent can be 
induced to change in response to a change in a biologically important variable, then it should 
be possible to design biologically responsive CEST agents. There are a number of 
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approaches to altering water molecule or proton exchange in PARACEST agents, among 
which three examples (26–29) are illustrated in Fig. 6.
As mentioned above, the strength of the lanthanide–water interaction affects the rate of 
water exchange in Eu-DOTA-tetraamide complexes that undergo dissociative exchange. The 
strength of interaction in these complexes can be modulated by altering the electronic effects 
of an aromatic amide substituent (26). As shown in Fig. 6a, a p-NO2-phenyl (electron-
withdrawing) amide substituent yields a PARACEST agent with slower water exchange 
compared with an agent containing a p-NH2-phenyl (electron-donating) substituent, and this 
difference is easily detected by CEST imaging. This observation suggests that properly 
designed responsive agents may enable detection and measurement of tissue characteristics, 
such as redox potential, O2, or other biological indexes of interest.
A second example of a responsive PARACEST agent iseuropium(III)1,4,7,10-
tetraazacyclocodecane-1,7-di-N-butylacetamide-4,10-di-N-[ethyl(dimethylpyridine) 
amino]acetamide (Eu-D2BAM-2BiPyAM) designed to sense Zn2+ ions. Here the four 
pyridyl groups positioned above the water coordination site of Eu bind a Zn2+ ion (28). This 
arrangement places a zinc-coordinated −OH group just above the Eu3+-bound water 
molecule, which appears to catalyze the exchange of protons between the Eu3+-bound water 
molecule and bulk water (Fig. 6b). In this complex the CEST is “on” in the absence of Zn2+, 
but it is turned “off “ when the catalytic −OH group is introduced by Zn2+.
In a similar way, a suitable compound can be arranged above the Eu3+-bound water 
molecule to slow down the water exchange and turn on the CEST effect. One example of 
such a system is given by the glucose-responsive PARACEST agent europium(III) 1,4,7,10-
tetraazacyclododecane-1,7-di-N-methylacetamide-4, 10-di-N-(m-phenylboronate)acetamide 
(Eu-D2MA-2PB) (21, 29), in which a single glucose molecule is bound by two 
phenylboronate groups above the Eu3+- water binding site. Phenylboronate groups form 
strong complexes with cis-dihydroxy compounds, such as sugars. These examples indicate 
that chemical exchange is relatively easy to modify in these complexes and that a variety of 
responsive agents can be envisioned for sensing various biological indexes of importance.
Many organic-based bis-phenylboronate structures display high affinity for binding fructose, 
but europium(III) 1,4,7,10-tetraazacyclododecane-1,7-di-N-methylacetamide-4,10-di-N-(m-
phenylboronate) acetamide (Eu-D2MA-2PB, Fig. 7) has a preference for binding glucose 
over fructose (29). This surprising result indicates that phenylboronate rings of Eu-
D2MA-2PB are oriented in such a way that their condensation with the cis-hydroxy groups 
of glucose is more favorable than with the cis-hydroxy groups of fructose.
Examination by ultraviolet absorption and circular dichroism spectroscopy confirmed that a 
1/1 Eu-D2MA-2PB–glucose adduct is the predominant structure in solution, with the 
glucose most likely bound via its 1,2-cis-hydroxy groups to one phenylboronate and via the 
4,6-cis-hydroxy groups to another phenylboronate. The steric encumbrance that arises from 
the position of the glucose molecule hinders the dissociation of the bound water molecule, 
thus slowing down water exchange. In this example, water exchange rate is reduced by a 
factor of about 2 when glucose is bound, and this is sufficient to “turn on” CEST function in 
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the complex. This agent has been used to monitor the distribution of tissue glucose in 
isolated perfused mouse livers, as illustrated in Fig. 7 (27).
PARACEST agents with nonwater exchange sites
PARACEST agents may contain secondary exchanging sites in addition to that of their water 
exchange site. One such example is the Yb-DOTA-tetraamide complex, discussed above, in 
which the amide protons of the pendant arms not only exchange with the bulk water but also 
experience a significant hyperfine shift from the lanthanide ion. Although the magnitude of 
the hyperfine shift is smaller than that of the bound water molecule, these protons are still 
useful for CEST activation. First, there are four or more amide protons compared with two 
in bound water protons. Second, unlike CEST from bound water, CEST arising from the 
amide protons have a marked pH dependence, just as in simple DIACEST systems (11, 30, 
31).
Thus, there is now considerable interest in amide protons of DOTA-tetraamide complexes 
for developing methods to image tissue pH in vivo (30). An interesting example of such a 
pH-responsive PARACEST agent is provided by a series of dendrimers bearing Yb-DOTAM 
complexes, as depicted in Fig. 8 (13). Here the pH sensitivity depends on the generation of 
the dendrimer, which may allow some structure tuning for optimum effect.
The amide protons of the Yb-DOTA-tetraamide complex are highly shifted (~ –20 ppm), and 
by attaching a large number of complexes on the surface of a dendrimer, a considerable 
enhancement in sensitivity can be achieved, depending on the size of the dendrimer.
Supramolecular and liposome-based CEST agents
Highly sensitive CEST agents were recently developed by moving beyond the simple 
complex towards supramolecular structures. Initially Aime and co-workers proposed ion-
paired assemblies of poly-L-arginine and Tm3+-DOTP (32) as CEST agents. A different 
supramolecular approach, dubbed LIPOCEST, was reported 2 years later and involves the 
incorporation of a shift reagent, such as Tm3+-DOTMA, inside a liposome (33). Liposomes 
are vesicular structures in the size range of about 50–300 nm (Fig. 9) comprising one or 
more phospholipid bilayers. The bilayer(s) enclose an inner aqueous pool that can be loaded 
with various water-soluble compounds. The liposomal wall is permeable to water, allowing 
water molecules of the inner aqueous environment of the liposomes to exchange with bulk 
water. A water-soluble paramagnetic shift reagent then shifts the resonance frequency of the 
encapsulated water away from the resonance frequency of bulk water, allowing selective 
saturation and LIPOCEST to be generated.
However, due to osmotic pressure limitations on agent concentration inside the liposomes, a 
strongly shifting lanthanide is needed to shift the Larmor frequency sufficiently, so that the 
RF pulse can saturate the liposome contents without saturating the bulk tissue water. 
Efficient PARACEST agents require lanthanides, such as Eu3+, with long water-binding 
lifetimes to allow the selective saturation of the bound proton pool. LIPOCEST agents have 
a similar requirement, as the water inside the liposomes behaves as a single pool shifted by 
the paramagnetic agent. The exchange time between intra-liposomal water and bulk tissue 
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water should be rapid but at the same time slow enough for selective saturation by an RF 
pulse. This is similar to the PARACEST case where the exchange rate must allow selective 
saturation.
In DIACEST and PARACEST the exchange time is controlled by the chemical properties of 
the agent. In LIPOCEST the exchange time is mainly determined by the chemical structure 
and architecture of the phospholipid bilayer of the liposome and by their surface-to-volume 
ratio. In the first LIPOCEST experiment, Tm-DOTMA at a concentration of 0.1 M was used 
as a shift reagent within the liposomes (mean diameter of 270 nm), resulting in the 
liposomal water resonating 3.1 ppm downfield from the bulk water outside the liposomes 
(33). Although the exchange rate was not reported, the Z spectrum of the aqueous dispersion 
of the liposomes containing the Tm complex recorded at 600 MHz shows a clear separation 
between the peaks of the free bulk water and the water within the liposome, as shown in Fig. 
9.
The sensitivity of this type of agent can be improved by increasing the average chemical 
shift of water within the liposomes that is proportional to Ln3+ concentration. Since this 
concentration is limited by osmosis, neutral shift reagents that do not require counter ions 
are preferable. Dimeric and trimeric shift reagents allow higher intra-liposomal lanthanide 
concentrations without the concomitant increase in osmolality. TERRENO et al. examined 
the effect of a dimeric shift reagent that was able to provide approximately twice the shift of 
a monomeric reference compound (34). However, a trimeric shift reagent was found to be 
only slightly more effective than the dimer, a result of the ligand structure chosen for the 
central lanthanide ion. The structure of the liposome bilayer can also influence the CEST 
effect. Amphiphilic shift reagents, for instance, can associate with the phospholipid wall, 
with the hydrophobic tail buried within the phospholipid wall, and the more polar shift 
reagent segment pointing out into the aqueous environment. This increases the total 
lanthanide concentration within the liposomes; the agent concentration per unit wall area is 
not limited by osmosis.
A further consideration in LIPOCEST is the size and shape of the liposomes. Provided that 
an adequate chemical shift is generated, smaller liposomes have the additional advantage of 
higher surface-to-volume ratio, and hence, faster exchange and a stronger CEST effect (35). 
Non-spherical liposomes can be used to induce larger chemical shifts by taking advantage of 
bulk magnetic susceptibility effects. Incorporating gadolinium 1,4,7,10-
tetraazacyclododecane-1-hydropropyl-4,7,10-triacetate (Gd-HP-DO3A) at 0.1 Osmol into a 
spherical liposome does not give rise to a shift in the intraliposomal water signal. However, 
incubation of the liposomes in an isotonic solution (0.28 Osmol) causes intraliposomal water 
to be expelled until the liposome interior is also 0.28 Osmol. This osmotic stress produces 
nonspherical liposomes and induces susceptibility effects that shift the resonance frequency 
of the intraliposomal water about 8 ppm downfield – double the shift achieved by the first 
experiment (36).
The shifts that can be generated by osmotically deforming the liposomes can be increased 
still further by using wall-bound amphiphilic shift reagents (37). This approach also permits 
control of the direction of the induced chemical shift, allowing the simultaneous detection of 
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two different agents in the same environment, which is an important CEST imaging 
capability (38). Liposomes were prepared incorporating either the thulium(III) or 
dysprosium(III) complexes of 1,4,7,10-tetraazacyclododecane-1-
dihexadecylacetamide-4,7,10-triacetate into the liposome wall and entrapping an aqueous 
solution of HP-DO3A complex of the same Ln3+ ion. After osmotic stress, the chemical 
shift of water within the nonspherical liposomes is shifted upfield in those liposomes 
containing Dy3+ but downfield in those containing Tm3+. Shifts as large as 45 ppm could be 
achieved by this method (37). Preparations of these nonspherical liposomes, one containing 
Dy3+ and the other Tm3+, were co-injected into a sample of beef and followed by CEST 
imaging, which showed the location of the injection. The Z spectrum of the site showed 
resolved peaks at 3 and 18 ppm.
In vivo applications of CEST imaging
In vivo imaging of endogenous CEST molecules, including imaging of pathological 
conditions in humans, is far more advanced than imaging of exogenous CEST agents. 
Although the focus of this review is exogenous CEST agents, an overview of animal and 
human experiments based on endogenous CEST molecules is also presented here. However, 
given the relatively early stage in the development of exogenous CEST agents, the majority 
of imaging experiments involving exogenous CEST agents is done in phantoms and perfused 
tissues. A few examples of in vivo images acquired in animal models are also presented, but 
as yet there is no reported imaging of exogenous CEST agents in humans.
In vivo imaging of endogenous biomolecules
Living organisms contain many proteins whose amide −NH protons exchange with water at 
rates suitable for CEST imaging. RF saturation of these endogenous resonances can provide 
useful information, even when the particular amide containing molecules is unknown. For 
instance, ZHOU et al. have reported that amide proton transfer (APT) in rat brain changes 
with pH during ischemia (39). JONES et al. also used this method to examine the difference 
between protein contents of brain tumor and its surroundings in patients at 3T (40).
Glycogen (a branched polymer of glucose), with its many −OH groups, is also an interesting 
endogenous CEST agent. Glycogen stores glucose in the liver, skeletal muscle, heart, and 
brain; its concentration is affected by diabetes, an all too common condition, and by several 
rare diseases. VAN ZIJL et al. have reported that CEST (glycoCEST) can be observed from 
the exchangeable –OH groups of glycogen in perfused mouse liver and that the glycogen 
content decreases when the liver is perfused with a glucose-free medium (41). 13C 
spectroscopy can also be used to assess in vivo glycogen noninvasively, but few clinical 
scanners have the necessary hardware for such investigations.
Glucosaminoglycans (GAGs) are another class of endogenous CEST molecules that are 
abundant and important to the function of several tissues, including cartilage. Each repeating 
unit of GAGs contains one –NH and three potentially CEST active –OH protons. The –NH 
proton is shifted 3.2 ppm relative to bulk water signal, and the –OH proton 0.9–1.9 ppm. 
LING et al. were able to observe “gagCEST” effects from –OH protons of GAG in the 
cartilage of both bovine specimens and in the knee of a human volunteer following 
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irradiation at 1 ppm away from the water resonance (42). This gagCEST effect could be 
observed in cartilage at 500 and 200, and even at 127 MHz (at 3 T) at which field the water 
and –OH resonances were only 64 Hz apart.
Conventional wisdom suggests that, in order for the CEST effect to be observable, chemical 
exchange should be slow, resulting in narrow resonances well separated from that of water. 
Typically –OH proton exchange rates are ~1000/s; thus, for both gag- and glycoCEST, the 
slow exchange condition has been breached. The glycoCEST paper (41) confirms that the –
OH line is not seen at all in a standard 1H NMR spectrum, confirming the violation of the 
slow exchange condition. This fact complicates quantification (not attempted in either of the 
above-mentioned experiments) but clearly does not abolish the CEST effect.
In vivo imaging of reporter genes
As described earlier, cells can be genetically modified to express proteins that can be imaged 
by CEST. The LRP reporter was the first to be imaged in 2007 by using APT for labeling of 
the amide protons of this reporter (14). Both the cells expressing LRP and control xenografts 
were inoculated in opposite sides of a mouse brain, followed by CEST signal intensity-
difference mapping, as shown in Fig. 10. This is the first example of a reporter gene targeted 
specifically for MRI-related investigation. It is a prototype CEST imaging of reporter genes 
that may have application in cell tracking and monitoring of gene expression and delivery.
In vivo imaging of PARACEST agents
In vivo retention and accumulation of PARACEST agents
The use of PARACEST agents in imaging generally suffers from low sensitivity and 
temporal resolution. Sensitivity can be improved by the use of agents that accumulate in the 
diseased tissue at higher concentrations, and agents with long in vivo retention times may be 
used to compensate for poor temporal resolution. One PARACEST agent reported by ALI & 
PAGEL to have both of these properties is europium(III) 1,7-bis[2-(methylene benzyloxy 
ether)-acetic acid] acetamide-4,10 bis(acetamidoacetic acid)-1,4,7,10-tetraazacyclododecane 
(Eu-DOTAM-OBnS2-Gly2-COOH) (43). The dynamic pharmacokinetics of the agent was 
successfully monitored in the vena cava, liver, and kidneys of mice by MRI. PARACEST 
effect was observed in the kidney cortex within 40 s post-injection, reaching maximum at 
4.6 min, and disappearing by 8.6 min. A 6–8% PARACEST effect in the liver could still be 
observed 30 min post-injection.
On-resonance paramagnetic chemical exchange effect
Achieving an observable PARACEST effect for fast exchanging complexes of Tm and Dy 
may require the application of RF saturation pulses that exceed the specific absorption rate 
(SAR) imposed limit, thus precluding their use in humans. However, an alternative 
methodology that would allow detection of these agents in vivo has recently been 
introduced; the method is termed “on-resonance paramagnetic chemical exchange effect”, 
hence, the acronym OPARACHEE (44). As the name implies, the method involves an “RF 
irradiation train” on free water resonance.
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Two of the main features of this new method are (i) much lower RF power deposition, and 
(ii) elimination of the need for a priori knowledge of the exact frequency of the lanthanide-
bound proton resonances. A broadband composite pulse decoupling scheme (WALTZ-16* 
pulse-train), is employed in this method, as the composite pulse train compensates for both 
B1 and B0 inhomogeneities (45, 46).
In vitro studies with thulium(III) [1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetamide] 
(Tm-DOTAM) and Dy-DOTAM show that OPARACHEE can detect agent concentrations of 
about 12 µM (44). The sequence was tested in vivo with a Tm-DOTAM-Gly compound, and 
the clearance of the agent through the mouse kidney was monitored (Fig. 11). Tm-DOT-AM-
Gly compound is sometimes referred to as Tm-DOTA-4AmC.
The lowest detectable dosage was a 2 mM bolus (~0.018 mmole/kg), producing an average 
maximum signal reduction of ~45% in the papilla of the kidney (47). This is a significant 
image contrast, so one would reasonably expect that lower doses would still be detectable. 
However, the application of WALTZ-16* train on free water leads to significant signal 
reduction due to direct saturation effects. At present, the sequence sensitivity of 
OPARACHEE is limited by the low SNR, rather than by the size of signal modulation (as 
opposed to standard PARACEST method).
Concluding remarks
Since the introduction of CEST in 2000, a variety of both diamagnetic (DIACEST) and 
paramagnetic (PARACEST) agents have been developed, as discussed in this review. The 
fundamental features that distinguish CEST contrast agents from relaxation contrast agents 
include the following.
1. Contrast can be turned on and off, thus allowing the acquisition of unenhanced 
images at the same time – just before or just after the acquisition of enhanced 
images. These conditions enable digital image subtraction, potentially allowing 
for smaller enhancement effects to be measurable than is possible with relaxation 
agents.
2. Methods for development of CEST agents sensitive to environmental parameters, 
such as pH, temperature, or metabolite concentration, are more versatile than 
those of responsive relaxation agents. With CEST proton exchange lifetimes can 
be measured quantitatively, hence giving the possibility of obtaining quantitative 
maps of the environmental parameter of interest.
3. CEST agents are more versatile for development of multiplex imaging (i.e. 
imaging multiple targets or process simultaneously) than are relaxation contrast 
agents, as CEST agents can be designed with differentially resonating 
exchanging sites, each of which can be targeted to a different site. A cocktail of 
such agents can then be administered at the same time to a patient for probing 
different targets, thus slashing the one target per exam limit of relaxation-based 
agents.
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CEST agents present some challenges in terms of application to human studies. Although 
their theoretical detection limit may be lower than that of relaxation-based agents, their 
experimental detection limit remains higher, due to practical limitations. While detection of 
μM concentrations of CEST agents has been reported, experiments have not necessarily been 
performed within the FDA guidelines for SAR deposition. Consequently, the range of 
concentrations of CEST agents that can be used safely in humans remains to be established.
In spite of the technical and practical challenges present in translating CEST imaging to 
human studies there is some evidence to suggest that at least for DIACEST agents this 
translation is readily achievable. JONES et al. (40) have shown that CEST can be applied to 
imaging human brain tumors using the CEST effect present from the amide protons of 
protein rich tumors. We suggest that it is only a matter of time until human “gagCEST” and 
“glycoCEST” studies appear in the literature. The advent of 7 T whole-body scanners 
increases the likelihood of the implementation of human CEST studies using endogenous 
agents.
The application of endogenous PARACEST agents to human studies may require longer 
stages of development. Both the technical challenges associated with the MR acquisitions of 
these agents as well as concerns related to the toxicity of these endogenous agents present 
larger barriers to adoption. However, the promise of responsive agents, together with the 
theoretical ability to monitor several targets or processes simultaneously, provide a strong 
motivation for addressing these challenges.
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Fig. 1. 
Schematic depicting chemical exchange between two pools of spins, separated by Δω (A = 
exchangeable protons on the agent and B = bulk water). The lower part of the graph depicts 
a decrease in the pool B signal following selective RF saturation of pool A.
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Fig. 2. 
Comparison of CEST spectra for typical DIACEST and PARACEST agents. The 
dramatically larger Δω displayed by the PARACEST agent makes activation of the agent by 
an applied RF pulse less ambiguous.
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Fig. 3. 
Chemical structures of small molecule DIACEST contrast agents, 5,6-dihydrouracil, 5-
hydroxytryptophan, and 2-imidazolidinethione.
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Fig. 4. 
Chemical structures of macromolecular DIACEST contrast agents. From top left: poly-L-
lysine (PLys), poly-L-glutamic acid (PGlu), polyallylamine, polyethylenimine (PEI).
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Fig. 5. 
Electron delocalization from ligand oxygen donors to the lanthanide ion decreases in the 
donor series, carboxylates > amides > ketones. This results in the weakest Eu3+-water 
interaction in the carboxylate systems and faster water exchange. In the extreme, ketone-
type ligands would contribute the least electron density, and thereby promote the strongest 
Eu3+-water interaction and slowest water exchange. Amide-containing systems fall between 
these extremes.
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Fig. 6. 
Illustrations of different ligand design concepts for “responsive” PARACEST agents. (a) 
Introduction of electron-withdrawing or electron-donating substituents into a single aromatic 
amide side-chain ligand alters water exchange and hence CEST. (b) At physiological pH the 
binding of Zn2+ to a site above the Eu3+-bound water molecule results in catalysis of proton 
exchange and “turns off “ CEST. (c) Binding of glucose over the Eu3+-bound water 
molecule slows water exchange and “turns on” CEST.
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Fig. 7. 
Ex vivo MR images of mouse livers (256 256 matrix, 40 40 mm field of view) after a bench 
perfusion with 10 mM EuX at 37C. The top liver in each panel was perfused without 
glucose, while the liver in the bottom of each panel was perfused with 10 mM glucose. The 
images were collected using a 4.7 T Varian Inova horizontal bore MR system with livers 
positioned over a 2.5 cm surface coil such that both livers could be imaged simultaneously. 
A spin-echo sequence with a Gaussian-shaped presaturation pulse (B1 peak power, 500 Hz; 
duration, 2 s) was used for imaging.
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Fig. 8. 
The amide protons of Yb-DOTAM complexes (structure on the right) exhibit a CEST effect 
that is highly pH dependent. By incorporating these PARACEST agents onto a dendrimer 
the pH range not only increases sensitivity but allows the pH range over which CEST 
changes to be tuned.
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Fig. 9. 
Schematic structure of large unilamellar phospholipid vesicles (liposomes, 100–300 nm), 
chemical structure of Tm-DOTMA, proton spectrum (upper curve), and Z spectrum (lower 
curve) of a suspension of vesicles; the vesicles contain 0.1 M of the agent, recorded at 600 
MHz. Reproduced from TERRENO et al. (34).
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Fig. 10. 
Images of mouse brain following inoculation with control and lysine-rich protein (LRP) 
expressing xenografts in opposite sides of the brain. (a) Anatomical image, (b) CEST signal 
intensity-difference map overlaid on the anatomical image. Reprinted with permission from 
Nat Biotechnol 2007.
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Fig. 11. 
Typical WALTZ-SE images of the kidney zoomed in on the areas marked on the anatomical 
images. Images were taken just before or after 20 mM (top) or 2 mM (bottom) bolus 
injection of Tm-DOTAM-Gly (reproduced from Magn Reson Med 2007 with permission). 
(a) Before injection, and (b-f) after injection: (b) 2 min 40 s, (c) 5 min 20 s, (d) 10 min 40 s, 
(e) 16 min, (f) 18 min 40 s. All timings refer to the beginning of injection and beginning of 
image acquisition. It appears that maximum intensity is observed around 3 min (b). As the 
agent clears through the kidney, the intensity gradually returns to the preinjection level (d-f).
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